Hoth Therapeutics Inc. (HOTH)
NASDAQ: HOTH
· Real-Time Price · USD
1.28
-0.01 (-0.78%)
At close: Aug 15, 2025, 3:59 PM
1.32
3.12%
After-hours: Aug 15, 2025, 07:39 PM EDT
Hoth Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.2M | -3.48M | -2.38M | -2.13M | -1.63M | -2.04M | -1.7M | -2.09M | -1.87M | -2.18M | -3.48M | -2.64M | -2.68M | -2.57M | -3.48M | -3.3M | -3.28M | -4.26M |
Depreciation & Amortization | -4.35K | 4.35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | 219.93K | 541.00 | 283.33K | 7.05K | 513.35K | 5.79K | 190.26K | 9.75K | 10.63K | 15.47K | 12.35K | 15.54K | 577.44K | 125.99K | 40.43K | 30.36K | 1.13M |
Other Working Capital | 370.58K | -370.58K | 330.84K | 163.41K | -6.55K | -157.8K | 93.78K | 86.31K | -131.15K | 47.23K | 148.04K | -4.34K | -8.53 | -92.56K | 49.32K | -2.45K | 35.73K | -88.02K |
Other Non-Cash Items | -555.98K | 850.5K | n/a | 50.75K | n/a | 580.00 | -229.83K | -33.75K | 166.58K | 26.93K | 458.48K | -36.52K | 36.45K | 3.05K | 148.07K | 142.39K | 33.24K | 47.15K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 386.97K | -386.97K | 354.44K | 163.41K | 33.7K | -197.1K | -1.15M | 293.49K | 247.01K | -143.47K | 454.61K | 279.72K | 5.62K | -145.47K | -696.16K | 410.35K | 449.83K | 365.91K |
Operating Cash Flow | -2.37M | -2.79M | -2.03M | -1.63M | -1.59M | -1.72M | -3.07M | -1.64M | -1.45M | -2.29M | -2.55M | -2.39M | -2.22M | -2.14M | -3.9M | -2.7M | -2.76M | -2.72M |
Capital Expenditures | -5 | 5.00 | -4 | n/a | 5.00 | n/a | n/a | n/a | n/a | n/a | -7.5K | 9.95K | -51.45K | -25K | -17.47K | -91.6K | 61.65K | -69.55K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.39B | 91.6K | n/a | 69.55K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9 | -1M | -526.95K | 1.03M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2 | 1.24M | n/a | 2.51B | 514.91K | 966.09K | 1.03M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.5 | 9.95 | 1.18K | -25 | -115.32M | -91.6K | -1.49M | -1.1M |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.5K | 9.95K | 1.18M | -25K | -17.48K | -579.12K | -525.97K | 957.21K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -136.73 | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -17.93K | n/a | n/a |
Other Financial Acitivies | 66.1K | n/a | n/a | n/a | n/a | n/a | n/a | 495.00 | n/a | 1.86K | 50.99K | n/a | n/a | n/a | 4.79B | n/a | 768.00 | 358.75K |
Financial Cash Flow | 66.1K | 7.07M | 1.06M | n/a | 3.68M | n/a | n/a | 2.41M | n/a | 8.91M | 50.99K | n/a | 5.99M | n/a | 18.18B | -100K | -136.73K | 18.43M |
Net Cash Flow | -2.3M | 4.28M | -983.84K | -1.63M | 2.09M | -1.73M | -2.54M | 283.44K | -1.5M | 6.62M | -2.51M | -2.38M | 4.94M | -2.16M | -3.91M | -3.41M | -3.45M | 16.67M |
Free Cash Flow | -2.37M | -2.79M | -2.03M | -1.63M | -1.59M | -1.72M | -3.07M | -1.64M | -1.45M | -2.29M | -2.56M | -2.38M | -2.27M | -2.16M | -3.92M | -2.79M | -2.7M | -2.79M |